With more than a dozen disease-modifying therapies (DMTs) available to treat multiple sclerosis (MS), the trea...
MARKET OUTLOOK Multiple Sclerosis (MS), a chronic immune-mediated disease of the nervous system, is classified as a rare disease in China because...
The maturing yet highly lucrative market for multiple sclerosis (MS) disease-modifying therapies (DMTs) will...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
With over a dozen immunomodulatory disease-modifying therapies (DMTs) available to treat multiple sclerosis (MS
The multiple sclerosis (MS) therapy market comprises more than a dozen disease-modifying therapies (DMTs) sp...
MARKET OUTLOOK Roche/Genentech achieved a clinical and regulatory milestone with the approval of Ocrevus for the treatment of primary-progressive...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
The treatment journey for multiple sclerosis (MS) patients in Europe is complicated and individualized, driven by the availability of a broad array...
Market Outlook In the EU5, access to disease-modifying therapies (DMT
Market Overview In a landmark FDA ruling in March 2017, Ocrevus became the first disease-modifying therapy (
Market Overview Ocrevus is the latest disease-modifying therapy (DMT) to launch for the treatment of relapsing forms of multipl...
A large array of clinically unique disease-modifying therapies (DMTs) is approved for the treatment of multiple sclerosis (
Market Outlook An increasing number of clinically unique disease-modifying therapies (DMTs) have been approved for the tre...
Get content updates to your inbox
Subscribe